Premarket Stock Movers — July 13, 2026: Why QTTB, AGEN, LGPS, FTRK & MIMI Are Surging

QTTB — Q32 Bio Inc. (+65.0%)

Q32 Bio is surging +65.0% to $18.51 in premarket trading on volume of 7,719,215 shares — more than 20× its 20-day average of 369,630. That kind of volume spike before the open signals serious institutional and retail attention converging on a single event.

Why it's moving: The catalyst is a highly anticipated clinical readout. On July 10, Q32 Bio announced it would report 36-week topline results from Part B of its SIGNAL-AA clinical trial of bempikibart in alopecia areata — a chronic autoimmune hair-loss condition — on July 13, which is today. The premarket surge suggests the market is either front-running an expected positive outcome or reacting to early data disclosure. This is a classic binary event trade: biotech stocks frequently make their largest single-day moves on clinical trial data, and the move can be as violent to the downside as the upside if results disappoint.

Technical picture heading in: Going into today's event, the StockSetups daily chart through July 10 showed a bullish MA stack (shorter-term moving averages above longer-term ones, confirming an uptrend structure) and a robust RS rating of 96 — meaning QTTB was already outperforming 96% of the US stock universe on a relative-strength basis. The conviction score was 84/100 with a Grade A, and the trend-template score of 8 suggests the stock was broadly aligned with Minervini's demanding uptrend criteria. RSI sat at 46 — not overbought — leaving room to run on a positive catalyst. The three outside down candlestick flagged on the prior close is a short-term bearish reversal pattern, meaning the stock had pulled back modestly into the event, but the broader trend structure remained constructive.

Short-squeeze context: The squeeze score is a moderate 43/100. Short interest stands at 906,228 shares with just 1.4 days to cover (the number of trading days it would theoretically take short-sellers to buy back all their borrowed shares at normal volume — the lower the number, the less fuel for a sustained squeeze). An SSR (short-sale restriction) is already active, meaning regulators have triggered a rule that limits additional short-selling after the prior day's decline. Smart-money signals include significant insider buying: OrbiMed and related entities purchased millions of shares in late May, a bullish signal from one of the most well-regarded biotech-focused investment firms.

Risk note: Clinical-trial binary events are among the highest-risk trades in the market. If the bempikibart data falls short of expectations, a sharp reversal is entirely possible. The stock is already trading 65% above Friday's close before a single regular-session share has changed hands.

AGEN — Agenus Inc. (+63.6%)

Agenus is jumping +63.6% to $5.48 premarket on 44.1 million shares — roughly 39× its 20-day average volume of 1,141,088. That is extraordinary premarket activity for a stock with a $139.5M market cap.

Why it's moving: The catalyst is a major financing announcement. According to headlines from Advfn and TipRanks this morning, Agenus has secured a financing package of up to $340 million to advance its colon cancer program. GuruFocus separately reports an $85 million private placement component of the deal, with the broader package structured to support the company's oncology pipeline. For a company sitting at a $139.5M market cap, a financing deal that large is transformative on paper — it significantly addresses near-term capital concerns and signals institutional confidence in the pipeline. That combination is why the stock is nearly doubling premarket.

Technical picture heading in: The setup heading into today was a contrarian one. The prior-day chart showed a bearish MA stack, an RS rating of just 7, a conviction score of 20/100, and a Grade D — meaning AGEN had been a consistent underperformer on StockSetups' scans before this morning. The stock was sitting 52.5% below its 52-week high, reflecting months of selling pressure. The hanging man candlestick on the prior close is typically a caution signal at a potential top of a short-term bounce. None of that prior weakness negates the move — financing news can override technical trends — but it does tell you the chart structure is being rebuilt from a weak base.

Short-squeeze angle: This is where AGEN gets interesting. The squeeze score is 87/100 — one of the highest readings in this morning's scan. Short interest sits at 4,777,994 shares with 8.3 days to cover, and short-volume on the prior day was a very high 85% of total volume.

A high days-to-cover figure means short-sellers need many days of average trading just to exit their positions. When a positive catalyst hits a stock this heavily shorted, short-sellers rush to cover (buy back shares) simultaneously, amplifying the upward move — this is a short squeeze. With 87/100 on StockSetups' squeeze score, the forced-buying dynamic is very much in play here and may be exaggerating the true fundamental reaction to the news. See our previous premarket recap for other examples of high-squeeze-score movers.

LGPS — LogProstyle Inc. (+55.3%)

LogProstyle is surging +55.3% to $1.29 in premarket trading on 31.2 million shares, versus a 20-day average of just 3,291,605 — nearly 10× normal volume for this $19.7M micro-cap consumer discretionary name.

Why it's moving: Two catalysts hit simultaneously this morning. Yahoo Finance reports that LogProstyle has announced a cash dividend of US$1,086,047 (US$0.046 per share) and has separately reported its fiscal year 2026 results. For a micro-cap trading around $1, a cash dividend of that size is notable — it signals the company has cash on hand and is returning it to shareholders. The combination of an earnings release and a dividend declaration is a rare double-catalyst for a stock this small, and it is clearly driving the premarket move.

Technical picture heading in: The prior chart showed a mixed MA stack, RSI of 56, and a conviction score of 21/100 with a Grade D. The RS rating was just 10, and the stock was sitting 52.3% below its 52-week high — a long-term downtrend. The trend-template score of 1 confirms the setup did not meet any meaningful uptrend criteria. There was no StockSetups scan lane signal ("non signal") on the prior close.

Float and squeeze read: LGPS has a free float of just 26.8% — meaning only about a quarter of outstanding shares are available for public trading. A low float (few shares in circulation) means even modest buying pressure can move the price dramatically, as there are simply fewer shares to absorb demand.

The squeeze score is a low 13/100, and short interest is only 108,717 shares with 0.1 days to cover, so this is not a short-squeeze story — this move is purely news- and sentiment-driven, amplified by the thin float. That dynamic can reverse equally fast once the initial excitement fades.

FTRK — Fast Track Group (+36.8%)

Fast Track Group is up +36.8% to $0.52 premarket on 42.4 million shares — a staggering 1,743× its 20-day average of just 24,302 shares. This is an extremely illiquid name in normal conditions; that volume ratio is one of the most extreme in this morning's scan and is a major red flag for volatility risk.

Why it's moving: Multiple catalysts from last week are converging. According to TipRanks and Quiver Quantitative (July 10), Fast Track Group signed a non-binding joint venture MOU with Sony Music Malaysia to promote artists in Southeast Asia, and separately secured $21.5 million in growth financing for entertainment and media expansion — including a $1.5 million convertible note and a $20 million equity line of credit. For a company with a market cap of $8.3M, a $21.5M financing package and a Sony Music partnership headline are headline-grabbing catalysts. The deals were announced on July 10 and appear to be driving delayed premarket momentum into July 13.

Technical picture heading in: The prior chart was weak across the board: a bearish MA stack, RSI of 41, ADX of 15 (suggesting no strong trend in either direction), conviction score of 4/100, and a Grade D. The stock was 61.2% below its 52-week high. An inverted hammer candlestick appeared on the prior close — a pattern that can signal a potential short-term reversal after a downtrend, though it requires confirmation. The StockSetups trend-template score of 1 means just one of the Minervini criteria is satisfied.

Risk note: At $0.52 and a market cap of $8.3M, FTRK is a penny stock operating in a highly speculative corner of the market. The convertible note financing, while providing capital, can also be dilutive to existing shareholders. The volume-to-average ratio here is extreme — this kind of illiquid, low-priced name can move violently in either direction with very little real-money activity. The squeeze score is just 3/100, so this is not a short-squeeze situation; it is purely a news and momentum reaction.

MIMI — Mint Inc Ltd (+34.1%)

Mint Inc is rising +34.1% to $2.89 premarket on 23.6 million shares, approximately 9.6× its 20-day average of 2,469,890. The $38.8M consumer discretionary micro-cap is the fifth-biggest premarket gainer this morning.

Why it's moving: No specific headline catalyst with a confirmed fundamental announcement is present in today's data. A July 12 StocksToTrade article notes that "MIMI Stock Climbs As Traders React To Tight Float And Strong Cash" — suggesting the move is being driven by awareness of the company's small float and cash position rather than a discrete news event. The catalyst here appears to be primarily technical and momentum-driven, with traders spotting the float characteristics and piling in.

Float and technical read: With a free float of 71.6%, this is not a classically tight-float name, but the absolute share count at this market cap is still small enough that volume surges matter. The prior-day chart showed a mixed MA stack, RSI of 42, conviction score of 49/100, and a Grade C — a middling technical setup. What stands out positively is the RS rating of 99, meaning MIMI was outperforming 99% of the US stock universe on relative strength heading into today, a genuinely noteworthy signal. The trend-template score of 3 suggests partial alignment with uptrend criteria.

Smart-money signal: CEO Chan Hoi Lung bought 211,879 shares ($638K) in May — a meaningful insider purchase that shows the chief executive has skin in the game at prices not far from current levels. The stock is sitting 80% below its 52-week high, so the broader trend remains deeply depressed despite the RS outperformance in recent weeks.

Risk reminder: With a squeeze score of just 3/100 and minimal short interest (14,880 shares, 0.2 days to cover), this move has no short-squeeze fuel. A 34% premarket gap on momentum alone — without a hard catalyst — is among the most dangerous situations for a new buyer, as these moves can evaporate quickly once regular-session liquidity arrives.

The bottom line

This morning's five biggest premarket movers span the full spectrum of risk: a binary biotech catalyst (QTTB), a transformative financing announcement on a heavily shorted name (AGEN), a dividend-plus-earnings double-catalyst micro-cap (LGPS), a penny-stock entertainment name reacting to last week's news (FTRK), and a pure momentum and float play (MIMI).

A few honest reminders before the 9:30 AM open:

• Premarket prices are not guaranteed to hold. Spreads are wider, volume is thinner, and the first minutes of the regular session frequently produce sharp reversals as institutional sellers arrive.
• Chasing stocks that are already up 35–65% before the open is high-risk by definition. The biggest single-day gainers are also frequently the biggest single-day losers in the following session.
• Patterns and squeeze signals can and do fail. High conviction scores and strong RS ratings improve probabilities — they do not eliminate risk.
• Penny stocks and micro-caps like FTRK and LGPS carry additional risks including thin liquidity, wider bid-ask spreads, and susceptibility to rapid reversals.

As always, manage your position size, use defined stops, and do your own research before acting on any of these names. StockSetups scans the full ~12,300-stock US universe every premarket morning, surfacing setups like these with conviction scores, squeeze scores, and smart-money signals — so you can see the technical picture each stock carried into the move, not just the headline. Check back after the close for a full after-hours recap.